{"id":"https://genegraph.clinicalgenome.org/r/d6c202fb-a393-4440-8e6e-11995fb9c6f1v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between NDUFA12 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of August 21, 2019. The NDUFA12 gene encodes the NADH:ubiquinone oxidoreductase (complex I) subunit A12, a non-catalytic complex I accessory protein which plays a role in complex I assembly and function within the mitochondria. Defects of this protein lead to complex I deficiency.\n\nThe NDUFA12 gene has been reported in relation to autosomal recessive Leigh syndrome spectrum in a single publication in 2011 (PMID: 21617257). Evidence supporting this gene-disease relationship includes case-level data and experimental data.\n\nThis curation included one homozygous variant identified in one case in one publication (PMID: 21617257).  No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known protein interactions and functional alteration in non-patient cells (PMIDs: 24717771, 27509854).\n\nIn summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel August 21, 2019 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d6c202fb-a393-4440-8e6e-11995fb9c6f1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/81f38f43-5e0c-4cb8-9be8-091f2c8a2c71","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/81f38f43-5e0c-4cb8-9be8-091f2c8a2c71_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2019-11-25T16:08:15.348Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/81f38f43-5e0c-4cb8-9be8-091f2c8a2c71_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81f38f43-5e0c-4cb8-9be8-091f2c8a2c71_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1eb0ec12-d72e-4a86-b3c2-6d1202de54ea_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The mitochondrial enriched fraction from patient fibroblasts showed an absence of NDUFA12 protein. (Figure 1C). A baculovirus construct expressing the wild-type NDUFA12 cDNA transfected into the patient derived fibroblast cell line rescued the complex I deficiency, demonstrated by an in-gel activity assay which showed a slightly decreased activity of complex I in the patient fibroblasts (71% of the control), with partial restoration of the activity after complementation (83% of the control).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d944c55-5e8c-4f3c-8b8e-9c700c1cbc9b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21617257","rdfs:label":"Case report","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"detectionMethod":"Homozygosity mapping identified three candidate genes which were screened by direct sequencing: LACTB, NDUFC1 and NDUFA12.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Complex I deficiency and Leigh syndrome (Meets GCEP criteria).\nEarly motor development was delayed while intellectual development was normal. From age 2 years, proband started losing motor abilities, especially in the right side of her body, affecting her balance. She had a scoliosis, and dystonia, which progressed over the following years and was treated with botulinum toxin injections of the affected muscles. She had growth retardation with height and weight around the 3rd centile. Vision and hearing are normal. She has severe muscular atrophy, hypotonia and severe dystonia. Hypertrichosis is present on the legs and, to a lesser degree, on the arms and back.\nCerebral MRI and MRS showed bilateral hyperintense signals in the globus pallidus, and elevated lactate in the entire cerebrum.\nPlasma lactate was 4.9 mmol/l (reference <2.1 mmol/l) and spinal fluid lactate 2.4 mmol/l (reference 1.1e1.8 mmol/l).\nComplex I deficiency: muscle and fibroblast complex I enzymatic activities of 11% and 60% of control values, respectively (figures 1A and 2A).","previousTesting":true,"previousTestingDescription":"Mutation analysis of complex I subunit encoding mtDNA genes and all mtDNA tRNA genes revealed no pathogenic mutations.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1eb0ec12-d72e-4a86-b3c2-6d1202de54ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21617257","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7be8554-2ed5-4431-b8cc-a63f348ea054","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018838.5(NDUFA12):c.178C>T (p.Arg60Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/31207"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/81f38f43-5e0c-4cb8-9be8-091f2c8a2c71_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81f38f43-5e0c-4cb8-9be8-091f2c8a2c71_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/512ccae5-31d5-45f0-a328-99fc75475cc3","type":"EvidenceLine","dc:description":"Depletion of NDUFA12 from HEK293 cells results in a reduction in complex I activity, reduced levels of the complex I holoenzyme and accumulation of CI assembly intermediates. NDUFA12 plays a role in complex I assembly and activity. Complex I deficiency is a key feature of Leigh syndrome in NDUFSA12 patients.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c44c3b3e-dd8f-4fbb-9fa1-f02657019f7e","type":"FunctionalAlteration","dc:description":"Complex I activity, assessed by standard methods, was significantly decreased in the NDUFA12 deficient lines (Fig 2). Activity of Complexes II, III and IV were not significantly altered. Data were supported by BN SDS-PAGE anlaysis followed by in-gel activity assays (Fig 3 B, C). 2D-BN/SDSâ€“PAGE showed that NDUFA12 deficient cells accumulated a 460 kDa intermediatary complex, which included NDUFS2 of the Q module (Fig 4).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24717771","rdfs:label":"Rak et al. (2014) 1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/81f38f43-5e0c-4cb8-9be8-091f2c8a2c71_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/568539a5-665d-4185-b085-b5cd4a5d5b1f","type":"EvidenceLine","dc:description":"NDUFA12 is present in complex I. According to Leigh map (Rahman et al. 2016)  a number of other non-catalytic subunits of complex I have been associated with Leigh syndrome: NDUFA1; NDUFA2, NDUFA9, NDUFA10, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS7, NDUFS8, NDUFV1, NDUFV2.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/af84b1a3-ef02-4eab-bb5b-54ba423d3489","type":"Finding","dc:description":"All genes are components of mitochondrial complex I. The study built on previous structural models of the complex I core and used further cryo EM mapping to model the location and interactions of all 31 supernumerary subunits present in complex I from Bos Taurus. Fig 1-4. NDUFA12 (B17.2) is one of five subunits which contain long loops running over the surface of the NADH dehydrogenase domain.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27509854","rdfs:label":"Zhu et al. (2016) Function 1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Limited","sequence":575,"specifiedBy":"GeneValidityCriteria6","strengthScore":4.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/g6mNvcWtuuU","type":"GeneValidityProposition","disease":"obo:MONDO_0009723","gene":"hgnc:23987","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_81f38f43-5e0c-4cb8-9be8-091f2c8a2c71-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}